Free tool
FAERS Monitor: Omegaven
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 210589 or its brand name (Omegaven, Fish Oil Triglycerides). Reports on generic versions are filed under their own applications.
Reports
91,003
Serious
44,188
49% of reports
Hospitalization
19,259
Death reported
4,595
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue8,464
- drug ineffective6,296
- diarrhoea6,166
- nausea6,153
- headache5,875
- pain5,511
- dizziness4,883
- arthralgia4,717
- pruritus4,449
- dyspnoea4,445
- asthenia4,179
- rash3,943
- off label use3,900
- vomiting3,405
- pain in extremity3,398
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 221 |
| 2005 | 296 |
| 2006 | 331 |
| 2007 | 552 |
| 2008 | 1,128 |
| 2009 | 2,089 |
| 2010 | 3,308 |
| 2011 | 3,404 |
| 2012 | 4,433 |
| 2013 | 4,921 |
| 2014 | 5,081 |
| 2015 | 7,791 |
| 2016 | 8,130 |
| 2017 | 6,889 |
| 2018 | 6,407 |
| 2019 | 5,620 |
| 2020 | 5,184 |
| 2021 | 4,412 |
| 2022 | 4,751 |
| 2023 | 4,222 |
| 2024 | 4,434 |
| 2025 | 4,205 |
| 2026 | 3,193 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,963,156 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| pruritusSignal | 4,449 | 2.7 | 2.6 | 4,775 |
| pain in extremitySignal | 3,398 | 2.7 | 2.6 | 3,600 |
| arthralgiaSignal | 4,717 | 2.6 | 2.6 | 4,848 |
| astheniaSignal | 4,179 | 2.6 | 2.5 | 4,093 |
| fatigueSignal | 8,464 | 2.5 | 2.5 | 8,037 |
| dizzinessSignal | 4,883 | 2.3 | 2.2 | 3,538 |
| diarrhoeaSignal | 6,166 | 2.2 | 2.2 | 4,220 |
| headacheSignal | 5,875 | 2.2 | 2.1 | 3,815 |
| rashSignal | 3,943 | 2.1 | 2.0 | 2,300 |
| painSignal | 5,511 | 2.1 | 2.0 | 3,168 |
| dyspnoea | 4,445 | 1.8 | 1.8 | 1,677 |
| nausea | 6,153 | 1.8 | 1.8 | 2,268 |
| vomiting | 3,405 | 1.7 | 1.6 | 948 |
| drug ineffective | 6,296 | 1.1 | 1.1 | 66 |
| off label use | 3,900 | 1.0 | 1.0 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.